September 28, 2016 9:07 AM ET

Pharmaceuticals

Company Overview of Obagi Medical Products, Inc.

Company Overview

Obagi Medical Products, Inc., a specialty pharmaceutical company, develops, markets, and sells topical aesthetic and therapeutic prescription skin care systems. It offers Obagi Nu-Derm System, which include prescription and OTC drugs that are used for the treatment of fine lines, wrinkles, acne, photo damage, hyperpigmentation, melasma, laxity, and skin sallowness; Obagi Condition and Enhance Systems used before and after surgical and non-surgical cosmetic procedures; Obagi-C Rx System that comprises Vitamin C with 4% hydroquinone system; and Professional-C products consisting of Vitamin C serums. The company also provides ELASTIderm Eye and Décolletage, which increases the elasticity and sk...

50 Technology Drive

Irvine, CA 92618

United States

Founded in 1988

203 Employees

Phone:

800-636-7546

Fax:

877-791-7096

Key Executives for Obagi Medical Products, Inc.

Chief Executive Officer, President and Director
Age: 57
Vice President of Manufacturing & Technical Services
Secretary and Director
Age: 46
Vice President of International Sales & Marketing
Vice President of Regulatory Affairs & QA
Compensation as of Fiscal Year 2016.

Obagi Medical Products, Inc. Key Developments

Valeant Reportedly Works With Morgan Stanley To Sell Solta Medical And Obagi Medical

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has engaged Morgan Stanley for the sale of Obagi Medical Products, Inc. and Solta Medical, Inc. to raise cash to reduce debt, according to people familiar with the matter. The two sale could fetch as much as $500 million and the sale process could start as early as this week, the people added. Bloomberg added that representatives at Valeant and Morgan Stanley declined to comment.

Valeant Considering Disposal Of Obagi Medical Products and Provenge

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) is considering disposal Of Obagi Medical Products, Inc. and Provenge it acquired last year. Valeant Pharmaceuticals divestitures could raise as much as $1 billion and attract other drugmakers with an interest in those areas.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Obagi Medical Products, Inc., please visit www.obagi.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.